Delivery Order SPE2DB22D2206-SPE2DB25FHY45
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,896.41 to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120 count) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $8,896.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a targeted cancer therapy medication. This contract, awarded on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a direct fulfillment order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award carries no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $8.9K delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serves as a critical pharmaceutical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) with a contract ceiling value of $8,896.42. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a purchase of pharmaceutical inventory supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) valued at $8,896.41, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a chemotherapy medication, under a firm fixed-price contract valued at $54,926.66. The contract was competitively awarded without set-aside provisions and is scheduled for completion by October 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,278.68, is for the supply of Tafinlar 75 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHY45Delivery Order
The Defense Logistics Agency awarded a $8,896.41 delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price delivery order, issued without set-aside designation, was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single shipment of this oncology medication through AmerisourceBergen's established federal pharmaceutical distribution network. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills medical commodity needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 7/17/25 |